These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21502241)

  • 1. Tracking vaccine-safety inquiries to detect signals and monitor public concerns.
    Miller E; Batten B; Hampton L; Campbell SR; Gao J; Iskander J
    Pediatrics; 2011 May; 127 Suppl 1():S87-91. PubMed ID: 21502241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
    LaRussa PS; Edwards KM; Dekker CL; Klein NP; Halsey NA; Marchant C; Baxter R; Engler RJ; Kissner J; Slade BA
    Pediatrics; 2011 May; 127 Suppl 1():S65-73. PubMed ID: 21502239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of the reactivity of vaccines administered in Texas from 1991 through 1999.
    Geier DA; Geier MR
    Tex Med; 2002 Jul; 98(7):50-4. PubMed ID: 12134752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complicated task of monitoring vaccine safety.
    Ellenberg SS; Chen RT
    Public Health Rep; 1997; 112(1):10-20; discussion 21. PubMed ID: 9018282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Vaccine Safety Datalink project.
    DeStefano F;
    Pharmacoepidemiol Drug Saf; 2001; 10(5):403-6. PubMed ID: 11802585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
    Souayah N; Nasar A; Suri MF; Qureshi AI
    J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way for providers to support vaccine safety.
    Haber P; Iskander J; Walton K; Campbell SR; Kohl KS
    Pediatrics; 2011 May; 127 Suppl 1():S39-44. PubMed ID: 21502243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Vaccine Safety Datalink: a model for monitoring immunization safety.
    Baggs J; Gee J; Lewis E; Fowler G; Benson P; Lieu T; Naleway A; Klein NP; Baxter R; Belongia E; Glanz J; Hambidge SJ; Jacobsen SJ; Jackson L; Nordin J; Weintraub E
    Pediatrics; 2011 May; 127 Suppl 1():S45-53. PubMed ID: 21502240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing data mining methods on the VAERS database.
    Banks D; Woo EJ; Burwen DR; Perucci P; Braun MM; Ball R
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):601-9. PubMed ID: 15954077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinovigilance in Europe--need for timeliness, standardization and resources.
    Lankinen KS; Pastila S; Kilpi T; Nohynek H; Mäkelä PH; Olin P
    Bull World Health Organ; 2004 Nov; 82(11):828-35. PubMed ID: 15640918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine attitudes, concerns, and information sources reported by parents of young children: results from the 2009 HealthStyles survey.
    Kennedy A; Basket M; Sheedy K
    Pediatrics; 2011 May; 127 Suppl 1():S92-9. PubMed ID: 21502253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization safety in US print media, 1995-2005.
    Hussain H; Omer SB; Manganello JA; Kromm EE; Carter TC; Kan L; Stokley S; Halsey NA; Salmon DA
    Pediatrics; 2011 May; 127 Suppl 1():S100-6. PubMed ID: 21502237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyarteritis nodosa reports to the vaccine adverse event reporting system (VAERS): implications for assessment of suspected vaccine-provoked vasculitis.
    Begier EM; Langford CA; Sneller MC; Wise RP; Ball R;
    J Rheumatol; 2004 Nov; 31(11):2181-8. PubMed ID: 15517631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccine safety inquiries to the centers for disease control and prevention immunization safety office.
    Miller ER; Moro PL; Shimabukuro TT; Carlock G; Davis SN; Freeborn EM; Roberts AL; Gee J; Taylor AW; Gallego R; Suragh T; Su JR
    Vaccine; 2023 Jun; 41(27):3960-3963. PubMed ID: 37248099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward better vaccine safety data and safer vaccination.
    Braun MM
    Pediatrics; 2008 Mar; 121(3):625-6. PubMed ID: 18310214
    [No Abstract]   [Full Text] [Related]  

  • 17. Adverse event reports following yellow fever vaccination.
    Lindsey NP; Schroeder BA; Miller ER; Braun MM; Hinckley AF; Marano N; Slade BA; Barnett ED; Brunette GW; Horan K; Staples JE; Kozarsky PE; Hayes EB
    Vaccine; 2008 Nov; 26(48):6077-82. PubMed ID: 18809449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS.
    ;
    Expert Rev Vaccines; 2009 Jun; 8(6):705-16. PubMed ID: 19485752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An innovative advance to increase the use of the vaccine information statement.
    Edlich RF; Olson DM; Olson BM; Greene JA; Gubler KD; Winters KL; Poe MJ; Britt LD; Long WB
    J Emerg Med; 2007 Jul; 33(1):81-9. PubMed ID: 17630084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.